| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |